Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia inpatients with Sjögren’s syndrome. - Shiozawa,K.; Tanaka,Y.; Yoshihara,R. (J Interferon Cytokine Res, 1998)